stella
beta
TVMR With the INNOVALVE System Trial - Early Feasibility Study — Stella
Home
/
Mitral Valve Regurgitation (Degenerative or Functional)
/
View on ClinicalTrials.gov
Recruiting
Back to Mitral Valve Regurgitation (Degenerative or Functional) trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(17 sites)
United States
Cedars-Sinai, Los Angeles, California
Naples Comprehensive Health, Naples, Florida
Piedmont Heart Institute, Atlanta, Georgia
Northwestern, Chicago, Illinois
University of Michigan Hospital and Health Systems, Ann Arbor, Michigan
Mayo Clinic, Rochester, Minnesota
Morristown Medical Center, Morristown, New Jersey
Northwell Health, Manhasset, New York
Cornell, New York, New York
NewYork-Presbyterian / Columbia University, New York, New York
Cleveland Clinic, Cleveland, Ohio
OhioHealth Research Institute, Columbus, Ohio
Oregon Health & Science Universtiy, Portland, Oregon
University of Pennsylvania, Philadelphia, Pennsylvania
Vanderbilt University Medical Center, Nashville, Tennessee
Ascension Saint Thomas, Nashville, Tennessee
Swedish Medical Center, Seattle, Washington